• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于多个数据集建立胃癌的四个基因预后模型。

Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets.

机构信息

Department of General Surgery, Nanchang University, The Second Affiliated Hospital of Nanchang University, NanChang, JiangXi, 330006, China.

出版信息

Cancer Med. 2021 May;10(10):3309-3322. doi: 10.1002/cam4.3654. Epub 2021 May 2.

DOI:10.1002/cam4.3654
PMID:33934516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8124107/
Abstract

Gastric cancer (GC) is a kind of malignancy with a high mortality and recurrence. An effective prediction model based on ideal biomarkers to assess prognosis could benefit patients for optimization of treatment. Bioinformatics has played an increasingly important role in the study of cancer diseases. Therefore, this study started with bioinformatics to establish a reliable prognostic model of gastric cancer. The gene expression data and clinical data of GC tissues and normal tissues were obtained from the Gene Expression Omnibus (GEO), Genotype-Tissue Expression (GTEx), and The Cancer Genome Atlas (TCGA) profile database. We finally identified a four gene signature and constructed a prognostic model. The results of internal and external validation showed that the model is highly reliable. In addition, we also constructed a nomogram based on the model, which was verified by a calibration curve to show its predicted accuracy. Comprehensive analysis indicated that the four genes in the model are related to the occurrence and development of tumors, perhaps they are potential targets for tumor treatment. Generally, this prognostic model can bring potential benefits to patients with gastric cancer.

摘要

胃癌(GC)是一种死亡率和复发率都很高的恶性肿瘤。建立一种基于理想生物标志物的有效预测模型来评估预后,可以使患者受益,从而优化治疗方案。生物信息学在癌症研究中发挥着越来越重要的作用。因此,本研究从生物信息学入手,建立了一种可靠的胃癌预后模型。从基因表达综合数据库(GEO)、基因型-组织表达(GTEx)和癌症基因组图谱(TCGA)数据库中获取 GC 组织和正常组织的基因表达数据和临床数据。我们最终确定了一个由四个基因组成的特征,并构建了一个预后模型。内部和外部验证的结果表明该模型具有高度可靠性。此外,我们还基于该模型构建了一个列线图,并通过校准曲线进行验证,以显示其预测的准确性。综合分析表明,模型中的四个基因与肿瘤的发生和发展有关,它们可能是肿瘤治疗的潜在靶点。总的来说,该预后模型可为胃癌患者带来潜在获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/0ab17e33aac1/CAM4-10-3309-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/b07cb75a3fb3/CAM4-10-3309-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/027a09b45175/CAM4-10-3309-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/c9d8a8dc28b4/CAM4-10-3309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/ae25fd4c9949/CAM4-10-3309-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/d4510b847a02/CAM4-10-3309-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/ebb5b814cffc/CAM4-10-3309-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/e8535642f081/CAM4-10-3309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/13a66df64035/CAM4-10-3309-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/ebb666896293/CAM4-10-3309-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/0ab17e33aac1/CAM4-10-3309-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/b07cb75a3fb3/CAM4-10-3309-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/027a09b45175/CAM4-10-3309-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/c9d8a8dc28b4/CAM4-10-3309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/ae25fd4c9949/CAM4-10-3309-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/d4510b847a02/CAM4-10-3309-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/ebb5b814cffc/CAM4-10-3309-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/e8535642f081/CAM4-10-3309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/13a66df64035/CAM4-10-3309-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/ebb666896293/CAM4-10-3309-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32ff/8124107/0ab17e33aac1/CAM4-10-3309-g007.jpg

相似文献

1
Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets.基于多个数据集建立胃癌的四个基因预后模型。
Cancer Med. 2021 May;10(10):3309-3322. doi: 10.1002/cam4.3654. Epub 2021 May 2.
2
Genome-wide identification of a novel miRNA-based signature to predict recurrence in patients with gastric cancer.基于全基因组鉴定的新型 miRNA 标志物预测胃癌患者的复发。
Mol Oncol. 2018 Dec;12(12):2072-2084. doi: 10.1002/1878-0261.12385. Epub 2018 Oct 10.
3
A 16-mRNA signature optimizes recurrence-free survival prediction of Stages II and III gastric cancer.一个 16-mRNA 标志物可优化 II 期和 III 期胃癌的无复发生存预测。
J Cell Physiol. 2020 Jul;235(7-8):5777-5786. doi: 10.1002/jcp.29511. Epub 2020 Feb 11.
4
Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.基于生物信息学分析鉴定的三 miRNA -signature 预测胃癌患者的预后。
World J Gastroenterol. 2018 Mar 21;24(11):1206-1215. doi: 10.3748/wjg.v24.i11.1206.
5
Identification of a Tumor Microenvironment-relevant Gene set-based Prognostic Signature and Related Therapy Targets in Gastric Cancer.基于肿瘤微环境相关基因集的胃癌预后特征及相关治疗靶点的鉴定。
Theranostics. 2020 Jul 9;10(19):8633-8647. doi: 10.7150/thno.47938. eCollection 2020.
6
Bioinformatics Analysis Reveals Prognostic Significance of the Macrophage Marker Gene Signature in Gastric Adenocarcinoma.生物信息学分析揭示巨噬细胞标志物基因特征在胃腺癌中的预后意义。
Front Biosci (Landmark Ed). 2024 May 6;29(5):172. doi: 10.31083/j.fbl2905172.
7
Construction and Validation of a Novel Prognostic Signature for Intestinal Type of Gastric Cancer.构建和验证一种新型的用于肠型胃癌的预后标志物。
Dis Markers. 2021 Aug 12;2021:5567392. doi: 10.1155/2021/5567392. eCollection 2021.
8
Comprehensive evaluation of FKBP10 expression and its prognostic potential in gastric cancer.胃癌中 FKBP10 表达的综合评估及其预后潜力。
Oncol Rep. 2019 Aug;42(2):615-628. doi: 10.3892/or.2019.7195. Epub 2019 Jun 11.
9
Genome-Scale Analysis Identified NID2, SPARC, and MFAP2 as Prognosis Markers of Overall Survival in Gastric Cancer.基于基因组规模分析鉴定 NID2、SPARC 和 MFAP2 作为胃癌总生存的预后标志物。
Med Sci Monit. 2021 Mar 24;27:e929558. doi: 10.12659/MSM.929558.
10
Discovery and validation of an expression signature for recurrence prediction in high-risk diffuse-type gastric cancer.高危弥漫型胃癌复发预测表达谱的发现和验证。
Gastric Cancer. 2021 May;24(3):655-665. doi: 10.1007/s10120-021-01155-y. Epub 2021 Feb 1.

引用本文的文献

1
Discoid Domain Receptors Signaling in Macrophages-Mediated Diseases.巨噬细胞介导疾病中盘状结构域受体信号传导
Int J Gen Med. 2025 Feb 19;18:907-926. doi: 10.2147/IJGM.S487093. eCollection 2025.
2
Comprehensive analysis of CPNE1 predicts prognosis and drug resistance in gastric adenocarcinoma.CPNE1的综合分析可预测胃腺癌的预后和耐药性。
Am J Transl Res. 2024 Jun 15;16(6):2233-2247. doi: 10.62347/NIYR2094. eCollection 2024.
3
Risk stratification in gastric cancer lung metastasis: Utilizing an overall survival nomogram and comparing it with previous staging.

本文引用的文献

1
Effect of miR-26a-5p on gastric cancer cell proliferation, migration and invasion by targeting COL10A1.miR-26a-5p 通过靶向 COL10A1 对胃癌细胞增殖、迁移和侵袭的影响。
Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1186-1194. doi: 10.26355/eurrev_202002_20170.
2
WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs.WebGestalt 2019:基因集分析工具包,具有全新的用户界面和 API。
Nucleic Acids Res. 2019 Jul 2;47(W1):W199-W205. doi: 10.1093/nar/gkz401.
3
The IL-17 Family of Cytokines in Health and Disease.白细胞介素-17 细胞因子家族在健康和疾病中的作用。
胃癌肺转移的风险分层:使用总生存列线图并与既往分期进行比较。
World J Gastrointest Surg. 2024 Feb 27;16(2):357-381. doi: 10.4240/wjgs.v16.i2.357.
4
Key Roles of p53 Signaling Pathway-Related Factors GADD45B and SERPINE1 in the Occurrence and Development of Gastric Cancer.p53 信号通路相关因子 GADD45B 和 SERPINE1 在胃癌发生发展中的关键作用。
Mediators Inflamm. 2023 Aug 24;2023:6368893. doi: 10.1155/2023/6368893. eCollection 2023.
5
Identification of a chemotherapy-associated gene signature for a risk model of prognosis in gastric adenocarcinoma through bioinformatics analysis.通过生物信息学分析鉴定用于胃腺癌预后风险模型的化疗相关基因特征。
J Gastrointest Oncol. 2022 Oct;13(5):2219-2233. doi: 10.21037/jgo-22-872.
6
Comprehensive analysis of chemokines family and related regulatory ceRNA network in lung adenocarcinoma.肺腺癌中趋化因子家族及相关调控ceRNA网络的综合分析
Heliyon. 2022 Nov 3;8(11):e11399. doi: 10.1016/j.heliyon.2022.e11399. eCollection 2022 Nov.
7
System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.基于细胞焦亡相关基因的系统分析鉴定 GSDMC 为胰腺腺癌的一个新治疗靶点。
J Transl Med. 2022 Oct 5;20(1):455. doi: 10.1186/s12967-022-03632-z.
8
Discoidin domain receptor 1 is a potential target correlated with tumor invasion and immune infiltration in gastric cancer.Discoidin domain receptor 1 是与胃癌侵袭和免疫浸润相关的潜在靶点。
Front Immunol. 2022 Jul 22;13:933165. doi: 10.3389/fimmu.2022.933165. eCollection 2022.
9
Identification of Potential Diagnoses Based on Immune Infiltration and Autophagy Characteristics in Major Depressive Disorder.基于免疫浸润和自噬特征识别重度抑郁症的潜在诊断
Front Genet. 2022 Apr 26;13:702366. doi: 10.3389/fgene.2022.702366. eCollection 2022.
Immunity. 2019 Apr 16;50(4):892-906. doi: 10.1016/j.immuni.2019.03.021.
4
UHRF1 mediates cell migration and invasion of gastric cancer.泛素样因子结合酶 1 介导胃癌细胞的迁移和侵袭。
Biosci Rep. 2018 Dec 18;38(6). doi: 10.1042/BSR20181065. Print 2018 Dec 21.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.TGF-β1-SOX9 轴诱导的 COL10A1 通过上皮-间充质转化促进胃癌的侵袭和转移。
Cell Death Dis. 2018 Aug 28;9(9):849. doi: 10.1038/s41419-018-0877-2.
7
Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer.已知易患性基因座中的罕见变异及其对肺癌风险的贡献。
J Thorac Oncol. 2018 Oct;13(10):1483-1495. doi: 10.1016/j.jtho.2018.06.016. Epub 2018 Jul 4.
8
High expression of COL10A1 is associated with poor prognosis in colorectal cancer.COL10A1的高表达与结直肠癌的不良预后相关。
Onco Targets Ther. 2018 Mar 20;11:1571-1581. doi: 10.2147/OTT.S160196. eCollection 2018.
9
Neoadjuvant chemotherapy for gastric cancer. Is it a must or a fake?胃癌的新辅助化疗:是必须,还是噱头?
World J Gastroenterol. 2018 Jan 14;24(2):274-289. doi: 10.3748/wjg.v24.i2.274.
10
Validation of the American Joint Committee on Cancer (AJCC) 8th edition stage system for gastric cancer patients: a population-based analysis.基于人群的分析验证美国癌症联合委员会(AJCC)第 8 版胃癌分期系统。
Gastric Cancer. 2018 May;21(3):391-400. doi: 10.1007/s10120-017-0770-1. Epub 2017 Oct 20.